News & Updates

Researchers from the University of Hong Kong (HKU) have identified lithium level thresholds associated with risks of hypothyroidism, hyperthyroidism, and stage ≥3 chronic kidney disease (CKD). This provides empirical evidence that can facilitate the development of clinical guidelines for lithium treatment in bipolar disorder.

A systematic review and meta-analysis conducted by researchers from the Chinese University of Hong Kong and Hong Kong Baptist University has shown that combining exercise with intermittent fasting (IF) is associated with greater reductions in fat mass and waist circumference (WC) as well as more substantial improvements in cardiometabolic health parameters in overweight and obese individuals than IF alone.

Replacing diet beverages with water over 18 months leads to greater weight loss, improved glycaemic control, and higher diabetes remission in women with type 2 diabetes (T2D) and overweight or obesity. The benefits were sustained throughout the 18-month trial.

In part 1 (dose ranging with and without dose escalation) of the phase II MariTide study, significant weight reduction and robust glycaemic improvement were achieved with maridebart cafraglutide (MariTide) – the first, long-acting, GIPR* antagonist and GLP-1R** agonist – in individuals with obesity or overweight and type 2 diabetes (T2D).